ATLANTA, GA – – (Newsfile Corp. – April 18, 2022) – – Holzer & Holzer, LLC informs investors that a class action lawsuit was filed against Aurinia Pharmaceuticals Inc. (“Aurinia” or the “Company”) (NASDAQ: AUPH). The lawsuit alleges, among other things, that Aurinia made certain false and/or misleading statements regarding the Company’s business, operations, and compliance policies. Specifically, Aurinia failed to disclose the Company was experiencing declining revenues for its only product, that the Company’s 2022 sales outlook would fall below expectations, and the Company had overstated its financial position and/or prospects for 2022. If you bought shares of Aurinia between May 7, 2021 and February 25, 2022, and you suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Marshall Dees, Esq. at email@example.com or Josh Karr, Esq. at firstname.lastname@example.org, by toll-free telephone at (888) 508-6832 or you may visit the firm’s website at www.holzerlaw.com to learn more. The deadline to ask the court to be appointed lead plaintiff in the case is June 14, 2022.